InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,178.00
(
1.88%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.78
(
0.17%
)
Bitcoin
59,389.96
(
0.45%
)

Replies to post #369 on Resverlogix Corp. (RVXCF)

Replies to #369 on Resverlogix Corp. (RVXCF)

bbhuey

02/24/17 12:04 PM

#370 RE: noretreat #369

Reservologix met with the FDA to redesign the phase 2a trial into two parts for kidney dialysis.Company intends to file their IND
in 2017.